FDA Warns About General Anesthesia and Sedation in the Young or Pregnant

Brain development may be affected by the drugs’ repeated or lengthy use

The FDA warns that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years old or in pregnant women during their third trimester may affect the development of children’s brains.

Consistent with animal studies, recent human studies suggest that a single, relatively short exposure to general anesthetic and sedation drugs in infants or toddlers is unlikely to have negative effects on behavior or learning, the FDA said in a Drug Safety Communication. However, further research is needed to fully characterize how early-life anesthetic exposure affects children’s brain development.

To better inform the public about this potential risk, the FDA is requiring warnings to be added to the labels of general anesthetic and sedation drugs. The agency will continue to monitor the use of these drugs in children and pregnant women and will update the public if additional information becomes available.

Anesthetic and sedation drugs are necessary for infants, children, and pregnant women who require surgery or other painful and stressful procedures, especially when they face life-threatening conditions requiring surgery that should not be delayed. In addition, untreated pain can be harmful to children and their developing nervous systems.

The FDA advises health care professionals to balance the benefits of appropriate anesthesia in young children and pregnant women against the potential risks, especially for procedures that may last longer than three hours or if multiple procedures are required in children younger than 3 years of age. In addition, practitioners should discuss with parents, caregivers, and pregnant women the benefits, risks, and appropriate timing of surgery or procedures requiring anesthetic and sedation drugs.

The agency advises parents and caregivers to discuss the potential adverse effects of anesthesia on brain development, as well as the appropriate timing of procedures that can be delayed without jeopardizing their child’s health, with their child’s health care professional. Pregnant women should have similar conversations with their health care professionals.

Published studies involving pregnant animals and young animals have shown that the use of general anesthetic and sedation drugs for more than three hours caused widespread loss of nerve cells in the brain. Studies in young animals suggest these changes result in long-term effects on the animals’ behavior or learning. Studies have also been conducted in children, some of which support findings from previous animal studies, particularly after repeated or prolonged exposure to these drugs early in life. All the studies in children had limitations, and it is unclear whether any negative effects seen in children’s learning or behavior were due to the drugs or to other factors, such as the underlying medical condition that led to the need for the surgery or procedure.

The FDA has been investigating the potential adverse effects of general anesthetic and sedation drugs on children’s brain development since the first animal study on this topic was published in 1999. Advisory committee meetings were held in 2007, 2011, and 2014. To coordinate and fund research in this area, the FDA also formed a partnership with the International Anesthesia Research Society called SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots). More research is needed to provide additional information about the safe use of these drugs in young children and pregnant women.

Source: FDA; December 14, 2016.